In this series, three experts in heart failure discuss the dilemma of discontinuation/reducing RAASi and lose the benefits of RAASi vs. continued RAASi and accept the presence of hyperkalemia. Moreover, the option of novel potassium binders is presented, when and how to use these agents?

This educational program consists of three presentations on hyperkalemia and RAASi use in patients with heart failure.

This course consists of the following:

• Risks associated with hyperkalemia - Prof. Stefan Anker, MD, PhD – Berlin, Germany
• RAASi as a fundamental pillar in heart failure - Prof. Andrew Coats, MD – Coventry, UK
• The clinical dilemma of RAASi and hyperkalemia - Prof. Javed Butler, MD – Jackson, MS, USA

How to obtain your CME certificate

• Watch the three 3 lectures, and anwer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Recall the definition and causes of hyperkalemia
• Explain the association between potassium levels and outcomes
• Reproduce findings from studies on the interplay between hyperkalemia, RAASi use and outcomes
• Recall findings from outcome trials with novel potassium binders
• Discuss when to use potassium binders

Expert faculty

• Prof. Stefan Anker, MD, PhD – Berlin, Germany
• Prof. Andrew Coats, MD – Coventry, UK
• Prof. Javed Butler, MD – Jackson, MS, USA

Target audience

This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in management of patients with heart failure.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Vifor Pharma.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.